Vitamin D Affects Genes for Cancer, Autoimmune Diseases: Study

Scientists at Oxford University have discovered a link between vitamin D deficiency and genes related to both cancer and autoimmune diseases.

More Americans Filed ADA Complaints in 2009

More Americans filed charges of discrimination against their employers in 2009 than in any other year since the ADA bill was passed, experts say, and the economy may be the primary cause.
illinois insurance quotes |

FDA Gives New Multiple Sclerosis Drug Priority Review Status

The U.S. Food and Drug Administration has granted priority review status to an experimental multiple sclerosis drug called cladribine.

Multiple Sclerosis Blood Vessel Theory Dealt Blow

A theory that multiple sclerosis is caused by obstruction in the blood vessels that carry blood from the brain back to the heart has been called into question by two recent studies.

Multiple Sclerosis Patients Demand Access to Unproven Treatment

One doctor’s so-called “liberation procedure” for MS is controversial and unapproved, but that hasn’t stopped scores of MS patients from gathering every bit of information on it in the hopes that it might treat or even cure their condition.

Brain Changes in Multiple Sclerosis May Trigger Depression

According to a new study, depression in people who have multiple sclerosis may be due to biological–and not psychological–reasons.

Marijuana-Based Multiple Sclerosis Drug Goes on Sale in the UK

A new cannabis-based drug called Sativex has gone on sale in the United Kingdom as a treatment for multiple sclerosis.

Protein May Help Brain Repair Damage from Neurological Conditions

Scientists at the Washington University School of Medicine in St. Louis have found that a protein that helps brain development in infants and children may also help the brain repair damage done by multiple sclerosis (MS) and other neurological diseases.

best anabolic steroids |

Being Mentally Active May Help Memory Problems from MS

According to a new study, being mentally active may help reduce memory and learning problems that often occur in people with multiple sclerosis.

FDA Panel Recommends First Oral Drug For Multiple Sclerosis

An expert panel that advises the U.S. Food and Drug Administration has recommended that the federal agency approve an oral drug called Gilenia as a first-line treatment for multiple sclerosis.

« Previous Entries Next Entries »